Karłowicz-Bodalska, K., Bęben, D., Janicka, N., Gądek, Ł., & Bodalska, G. (2024). Intestinal Microbiota as a Determinant of Effectiveness and Safety of Anticancer Therapy. Farmacja Polska, 80(2), 101-110. https://doi.org/10.32383/farmpol/190217
Chicago Style (17th ed.) CitationKarłowicz-Bodalska, Katarzyna, Dorota Bęben, Natalia Janicka, Łukasz Gądek, and Grażyna Bodalska. "Intestinal Microbiota as a Determinant of Effectiveness and Safety of Anticancer Therapy." Farmacja Polska 80, no. 2 (2024): 101-110. https://doi.org/10.32383/farmpol/190217.
MLA (9th ed.) CitationKarłowicz-Bodalska, Katarzyna, et al. "Intestinal Microbiota as a Determinant of Effectiveness and Safety of Anticancer Therapy." Farmacja Polska, vol. 80, no. 2, 2024, pp. 101-110, https://doi.org/10.32383/farmpol/190217.